APA (7th ed.) Citation

Liu, G., Liang, T., Ai, H., Wang, S., Yin, S., Wang, X., . . . Yin, Q. (2026). Upregulation of TCF1 and BCL11B in CD8+ effector T cells predicts favorable response to ibrutinib in patients with chronic lymphocytic leukemia. Communications Biology, 1. https://doi.org/10.1038/s42003-026-10201-3

Chicago Style (17th ed.) Citation

Liu, Ge, et al. "Upregulation of TCF1 and BCL11B in CD8+ Effector T Cells Predicts Favorable Response to Ibrutinib in Patients with Chronic Lymphocytic Leukemia." Communications Biology 2026: 1. https://doi.org/10.1038/s42003-026-10201-3.

MLA (9th ed.) Citation

Liu, Ge, et al. "Upregulation of TCF1 and BCL11B in CD8+ Effector T Cells Predicts Favorable Response to Ibrutinib in Patients with Chronic Lymphocytic Leukemia." Communications Biology, 2026, p. 1, https://doi.org/10.1038/s42003-026-10201-3.